Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=Person:%22Lin%2C+Swan%22
/vufind/Search/Results?lookfor=Person:%22Lin%2C+Swan%22
Search /vufind/Search2/Results?lookfor=Person:%22Lin%2C+Swan%22
PubPharm (28)
1
Effects of H2-Receptor Antagonists on the Exposure of Dacomitinib
enthalten in:
Preprints.org
| 2024
von
Liu, J.
|
Lin, S.
|
Huynh, A.
| +1
Wird geladen...
2
Effects of H2-Receptor Antagonists on the Exposure of Dacomitinib
enthalten in:
Pharmaceutics
| 2024
von
Liu, J.
|
Lin, S.
|
Huynh, A.
| +1
Wird geladen...
3
Correction to : A Phase I Study to Evaluate the Pharmacokinetics and Safety of Lorlatinib in Adults with Mild, Moderate, and Severe Renal Impairment
enthalten in:
European journal of drug metabolism and pharmacokinetics
| 2022
von
Lin, S.
|
Gong, J.
|
Canas, G.
| +5
ErratumFor: Eur J Drug Metab Pharmacokinet. 2022 Mar;47(2):235-245. - PMID 35018553
Wird geladen...
4
A Phase I Study to Evaluate the Pharmacokinetics and Safety of Lorlatinib in Adults with Mild, Moderate, and Severe Renal Impairment
enthalten in:
European journal of drug metabolism and pharmacokinetics
| 2022
von
Lin, S.
|
Gong, J.
|
Canas, G.
| +5
ErratumIn: Eur J Drug Metab Pharmacokinet. 2022 Mar 8;:. - PMID 35258796
Wird geladen...
5
Correction to: A Phase I Study to Evaluate the Pharmacokinetics and Safety of Lorlatinib in Adults with Mild, Moderate, and Severe Renal Impairment
enthalten in:
European journal of drug metabolism and pharmacokinetics
| 2022
von
Lin, S.
|
Gong, J.
|
Canas, G.
| +5
Wird geladen...
6
Correction to: A Phase I Study to Evaluate the Pharmacokinetics and Safety of Lorlatinib in Adults with Mild, Moderate, and Severe Renal Impairment
enthalten in:
European journal of drug metabolism and pharmacokinetics
| 2022
von
Lin, S.
|
Gong, J.
|
Canas, G.
| +5
Wird geladen...
7
Correction to: A Phase I Study to Evaluate the Pharmacokinetics and Safety of Lorlatinib in Adults with Mild, Moderate, and Severe Renal Impairment
enthalten in:
European journal of drug metabolism and pharmacokinetics
| 2022
von
Lin, S.
|
Gong, J.
|
Canas, G.
| +5
Wird geladen...
8
A Phase I Study to Evaluate the Pharmacokinetics and Safety of Lorlatinib in Adults with Mild, Moderate, and Severe Renal Impairment
enthalten in:
European journal of drug metabolism and pharmacokinetics
| 2022
von
Lin, S.
|
Gong, J.
|
Canas, G.
| +5
Wird geladen...
9
A Phase I Study to Evaluate the Pharmacokinetics and Safety of Lorlatinib in Adults with Mild, Moderate, and Severe Renal Impairment
enthalten in:
European journal of drug metabolism and pharmacokinetics
| 2022
von
Lin, S.
|
Gong, J.
|
Canas, G.
| +5
Wird geladen...
10
A Phase I Study to Evaluate the Pharmacokinetics and Safety of Lorlatinib in Adults with Mild, Moderate, and Severe Renal Impairment
enthalten in:
European journal of drug metabolism and pharmacokinetics
| 2022
von
Lin, S.
|
Gong, J.
|
Canas, G.
| +5
Wird geladen...
1
2
3
Nächster »
[3]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
28
Aufsätze
23
E-Artikel
23
E-Ressourcen
5
Gedruckte Aufsätze
Zeitschriftentitel
8
Cancer chemotherapy and pharmacology
8
European journal of drug metabolism and pharmac...
4
Pharmaceutical research
2
Journal of clinical pharmacology
2
Pharmaceutics
2
The Journal of Clinical Pharmacology
1
Preprints.org
1
Therapeutic drug monitoring
Alle anzeigen ...
weniger ...
Thema
9
Journal Article
5
Hedgehog
5
Smoothened inhibitor
4
Acute myeloid leukemia
4
CYP3A inducers
4
Crizotinib
4
Dexamethasone
4
Exposure–response
4
Non-small cell lung cancer
4
Overall survival
4
Research Support, Non-U.S. Gov't
4
Targeted therapy
2
Benzimidazoles
2
K673DMO5H9
2
Phenylurea Compounds
2
Research Support, N.I.H., Extramural
2
acute myeloid leukemia
2
glasdegib
1
04079A1RDZ
1
53AH36668S
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
19
2020-
9
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
26
Englisch
Haven't found what you're looking for?
Wird geladen...